Schrodinger, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:SDGR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 144.06 M-52.2 M-61.87 M-16.09 M-14.83 M -145 M Cash from investing activities 30.63 M-55.6 M11.46 M71.41 M44.6 M 71.86 M Cash from financing activities 409 K2.02 M307 K197 K569 K 3.09 M Free cash flow 144.06 M-52.2 M-61.87 M-16.09 M-14.83 M -145 M

News

Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR)

Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?

AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Schrödinger, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SDGR) 2026-05-06

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

AI Revolutionizing Biopharma: Faster, Better, Cheaper (NYSEARCA:XLV)

Recursion Pharmaceuticals May Be Losing Ground To Its Peers (NASDAQ:RXRX)

Schrodinger: AI Threat Is Looming Large (NASDAQ:SDGR)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit